Evidence-Based Medicine Guidelines
Bortezomib for the treatment of multiple myeloma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bortezomib for the Treatment of Multiple Myeloma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305230/all/_________Bortezomib_for_the_treatment_of_multiple_myeloma______.
Bortezomib for the treatment of multiple myeloma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305230/all/_________Bortezomib_for_the_treatment_of_multiple_myeloma______. Accessed December 2, 2024.
Bortezomib for the treatment of multiple myeloma. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305230/all/_________Bortezomib_for_the_treatment_of_multiple_myeloma______
Bortezomib for the Treatment of Multiple Myeloma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305230/all/_________Bortezomib_for_the_treatment_of_multiple_myeloma______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bortezomib for the treatment of multiple myeloma
ID - 1305230
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305230/all/_________Bortezomib_for_the_treatment_of_multiple_myeloma______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
